/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

P

Pamela Vig

SciClone Pharmaceuticals (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

88

Papers

2.9K

Citations

20

h-index

29

i10-index

Pamela Vig is an academic researcher from SciClone Pharmaceuticals (United States). The author has contributed to research in topics: Pediatric Hepatobiliary Diseases and Treatments & Liver Diseases and Immunity & Drug Transport and Resistance Mechanisms. The author has an h-index of 20, co-authored 75 publications.

ORCID: 0009-0000-4226-5435

Research Topics

Pediatric Hepatobiliary Diseases and Treatments Liver Diseases and Immunity Drug Transport and Resistance Mechanisms Liver Disease Diagnosis and Treatment Gallbladder and Bile Duct Disorders

Papers by this author

works

Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study

2021 · The Lancet · 162 citations

https://doi.org/10.1016/s0140-6736(21)01256-3

Emmanuel Gonzalès Winita Hardikar Michael Stormon Alastair Baker

Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA

2023 · Hepatology · 30 citations

https://doi.org/10.1097/hep.0000000000000727

Bettina E. Hansen Shannon M. Vandriel Pamela Vig Will Garner

Maralixibat Reduces Serum Bile Acids and Improves Cholestatic Pruritus in Adolescents With Alagille Syndrome

2025 · Liver International · 5 citations

https://doi.org/10.1111/liv.16201

Gideon M. Hirschfield Shannon M. Vandriel Douglas Mogul Marshall Baek

The burden of Alagille syndrome: uncovering the potential of emerging therapeutics – a comprehensive systematic literature review

2025 · Journal of Comparative Effectiveness Research · 3 citations

https://doi.org/10.57264/cer-2024-0188

Philip Bufler Robin Howard Lucia Quadrado Guy Lacey

P142: Efficacy, safety and tolerability of chenodeoxycholic acid in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized, placebo-controlled phase 3 study*

2024 · Genetics in Medicine Open · 1 citations

https://doi.org/10.1016/j.gimo.2024.101039

Andrea E. DeBarber Yaz Y. Kisanuki Paulo Ribeiro Nóbrega Ryan Himes

The relationship between serum bile acids and event-free survival following the use of maralixibat for progressive familial intrahepatic cholestasis: data from MARCH/MARCH-ON

2025 · Digestive and Liver Disease · 1 citations

https://doi.org/10.1016/j.dld.2025.01.126

Lorenzo D’Antiga Richard J. Thompson Simon Horslen DB Mogul

Research topics

topics

Pediatric Hepatobiliary Diseases and Treatments

Liver Diseases and Immunity

Drug Transport and Resistance Mechanisms

Liver Disease Diagnosis and Treatment

Gallbladder and Bile Duct Disorders

Chat about Author

Papers

Chat

Click to start Chat